Julia Russell, Associate Director, Protiviti.
June 12, 2020
-
Compliance requirements and beyond: Evaluating the effectiveness of your compliance program and remedial efforts to implement or improve one in the face of the opioid epidemic
-
Digging into the common findings of Opioid Compliance Review and Drug Diversion Reviews
-
Using analytics to target key risks related to prescribing, drug diversion, and compliance with system and regulatory policies